Chronic Thromboembolic Pulmonary Hypertension, Post Thrombotic Syndrome, Quality of Life, Venous Thromboembolic Disease
Conditions
Keywords
Post thrombotic syndrome, Edoxaban, Vitamin K antagonist, Chronic Thromboembolic Pulmonary Hypertension, Quality of Life
Brief summary
The HOKUSAI post VTE study contains of two different research questions; one on the long term outcomes of deep vein thrombosis and one on the long term effects of pulmonary embolism, post thrombotic syndrome (PTS) and chronic thromboembolic pulmonary hypertension (CTEPH) respectively. Our aim of the study is to compare the long term outcomes along with the quality of life assessment of VTE in a group treated with heparin+VKA versus a group treated with heparin+edoxaban in the acute setting.
Interventions
OTHERObservation
No intervention
Sponsors
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Participant in the HOKUSAI VTE trial
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Post thrombotic syndrome (PTS) | up to 10 years | PTS according to Villalta |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Chronic thromboembolic pulmonary hypertension (CTEPH) | up to 10 years | according to clinical and objective criteria |
Countries
Netherlands
Contacts
Primary ContactIngrid Bistervels, MD
Backup ContactRoisin Bavalia, MD
Outcome results
None listed